The de novo DNA methyltransferase DNMT3A in development and cancer

Epigenetics. 2014 May;9(5):669-77. doi: 10.4161/epi.28324. Epub 2014 Mar 3.

Abstract

DNA methylation, one of the best-characterized epigenetic modifications, plays essential roles in development, aging and diseases. The de novo DNA methyltransferase DNMT3A is responsible for the establishment of de novo genomic DNA methylation patterns and, as such, involved in normal development as well as in many diseases including cancer. In recent years, our understanding of this important protein has made significant progress, which was facilitated by stunning development in the analysis of the DNA methylome of multiple organs and cell types. In this review, recent developments in the characterization of DNMT3A were discussed with special emphasis on the roles of DNMT3A in development and cancer.

Keywords: DNA methylation; DNMT3A; cancer; development; epigenetics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • DNA (Cytosine-5-)-Methyltransferases / metabolism*
  • DNA Methylation
  • DNA Methyltransferase 3A
  • Embryonic Development
  • Growth and Development*
  • Humans
  • Neoplasms / enzymology*

Substances

  • DNMT3A protein, human
  • Dnmt3a protein, mouse
  • DNMT3L protein, human
  • Dnmt3l protein, mouse
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA Methyltransferase 3A